# Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic Leukemia

> **NCT02808442** · PHASE1 · COMPLETED · sponsor: **Institut de Recherches Internationales Servier** · enrollment: 13 (actual)

## Conditions studied

- Refractory B-cell Acute Lymphoblastic Leukemia
- Relapsed B-cell Acute Lymphoblastic Leukemia

## Interventions

- **BIOLOGICAL:** UCART19

## Key facts

- **NCT ID:** NCT02808442
- **Lead sponsor:** Institut de Recherches Internationales Servier
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-03
- **Primary completion:** 2020-09-17
- **Final completion:** 2020-11-04
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2021-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02808442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02808442, "Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02808442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*